almagate has been researched along with n-methylaspartate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartz-Schmidt, KU; Bolz, S; Choragiewicz, TJ; Fiedorowicz, M; Henke-Fahle, S; Schuettauf, F; Thaler, S; Tura, A; Yoeruek, E; Ziemssen, F; Zrenner, E | 1 |
1 other study(ies) available for almagate and n-methylaspartate
Article | Year |
---|---|
Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cell Count; Excitatory Amino Acid Agonists; Female; Injections; Mitochondria; N-Methylaspartate; Ranibizumab; Rats; Rats, Inbred BN; Retinal Ganglion Cells; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |